Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-Thy1/CD90 Antibody-APC (9A348)
😃Good
Catalog No. TMAY-02832A
Alias Thy-1 cell surface antigen, CD90
Anti-Thy1/CD90 Antibody-APC (9A348) is a APC-conjugated Mouse antibody targeting Thy1/CD90. Anti-Thy1/CD90 Antibody-APC (9A348) can be used in FCM.
Anti-Thy1/CD90 Antibody-APC (9A348)
Anti-Thy1/CD90 Antibody-APC (9A348)
😃Good
Catalog No. TMAY-02832AAlias Thy-1 cell surface antigen, CD90
Anti-Thy1/CD90 Antibody-APC (9A348) is a APC-conjugated Mouse antibody targeting Thy1/CD90. Anti-Thy1/CD90 Antibody-APC (9A348) can be used in FCM.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 T | $104 | 7-10 days | |
| 100 T | $328 | 7-10 days |
Bulk & Custom
Add to Cart
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Antibody Type: Mouse Monoclonal Application: FCM Reactivity: Human |
| Alias | Thy-1 cell surface antigen, CD90 |
| Ig Type | Mouse IgG1 |
| Clone | 9A348 |
| Reactivity | Human |
| Verified Activity | Flow cytometric analysis of Human Thy1(CD90) expression on HEL92 cells. Cells were stained with APC-conjugated anti-Human Thy1(CD90). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. |
| Application | FCM |
| Recommended Dose | 10 μl/Test, 0.1 mg/ml |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human Thy1/CD90 (rh Thy1/CD90; TMPY-04897; NP_006279.2; Met1-Cys130) and conjugated with APC under optimum conditions, the unreacted APC was removed. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | PBS solution containing 0.5% BSA and 0.03%ProClin300 |
| Research Background | Thy-1 membrane glycoprotein, also known as Thy-1 antigen, CD90 and THY1, is a cell membrane protein which contains 1 Ig-like V-type (immunoglobulin-like) domain. It is a glycophosphatidylinositol-linked glycoprotein expressed on the surface of neurons, thymocytes, subsets of fibroblasts, endothelial cells, mesangial cells and some hematopoietic cells. It has been identified on a variety of stem cells and at varying levels in non-lymphoid tissues such as on fibroblasts, brain cells, and activated endothelial cells. Thy-1 is evolutionarily conserved, developmentally regulated, and often has dramatic effects on cell phenotype. Thy-1 is a 25-37 kDa glycosylphosphatidylinositol (GPI)-anchored protein involved in T cell activation, neurite outgrowth, apoptosis, tumor suppression, wound healing, and fibrosis. To mediate these diverse effects, Thy-1 participates in multiple signaling cascades. Thy-1 is an important regulator of cell-cell and cell-matrix interactions, with important roles in nerve regeneration, metastasis, inflammation, and fibrosis. |
| Conjucates | APC |
| Others Formats | Unconjugated/Biotin/PerCP/FITC/PE |
| Antibody Types Available | 6 |
| Immunogen | Recombinant Protein: Human Thy1/CD90 Protein (TMPY-04897) |
| Antigen Species | Human |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-Thy1/CD90 Antibody-APC (9A348) | purchase Anti-Thy1/CD90 Antibody-APC (9A348) | Anti-Thy1/CD90 Antibody-APC (9A348) cost | order Anti-Thy1/CD90 Antibody-APC (9A348)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.